Global Skeletal Disease Drug Market Research Report 2018
Skeletal Disease Drug Report by Material, Application, and Geography – Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
The report firstly introduced the Skeletal Disease Drug basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Skeletal Disease Drug Market;
3.) the North American Skeletal Disease Drug Market;
4.) the European Skeletal Disease Drug Market;
5.) market entry and investment feasibility;
6.) the report conclusion.
The report firstly introduced the Skeletal Disease Drug basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Skeletal Disease Drug Market;
3.) the North American Skeletal Disease Drug Market;
4.) the European Skeletal Disease Drug Market;
5.) market entry and investment feasibility;
6.) the report conclusion.
PART I SKELETAL DISEASE DRUG INDUSTRY OVERVIEW
CHAPTER ONE SKELETAL DISEASE DRUG INDUSTRY OVERVIEW
1.1 Skeletal Disease Drug Definition
1.2 Skeletal Disease Drug Classification Analysis
1.2.1 Skeletal Disease Drug Main Classification Analysis
1.2.2 Skeletal Disease Drug Main Classification Share Analysis
1.3 Skeletal Disease Drug Application Analysis
1.3.1 Skeletal Disease Drug Main Application Analysis
1.3.2 Skeletal Disease Drug Main Application Share Analysis
1.4 Skeletal Disease Drug Industry Chain Structure Analysis
1.5 Skeletal Disease Drug Industry Development Overview
1.5.1 Skeletal Disease Drug Product History Development Overview
1.5.1 Skeletal Disease Drug Product Market Development Overview
1.6 Skeletal Disease Drug Global Market Comparison Analysis
1.6.1 Skeletal Disease Drug Global Import Market Analysis
1.6.2 Skeletal Disease Drug Global Export Market Analysis
1.6.3 Skeletal Disease Drug Global Main Region Market Analysis
1.6.4 Skeletal Disease Drug Global Market Comparison Analysis
1.6.5 Skeletal Disease Drug Global Market Development Trend Analysis
CHAPTER TWO SKELETAL DISEASE DRUG UP AND DOWN STREAM INDUSTRY ANALYSIS
2.1 Upstream Raw Materials Analysis
2.1.1 Upstream Raw Materials Price Analysis
2.1.2 Upstream Raw Materials Market Analysis
2.1.3 Upstream Raw Materials Market Trend
2.2 Down Stream Market Analysis
2.1.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis
PART II ASIA SKELETAL DISEASE DRUG INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER THREE ASIA SKELETAL DISEASE DRUG MARKET ANALYSIS
3.1 Asia Skeletal Disease Drug Product Development History
3.2 Asia Skeletal Disease Drug Competitive Landscape Analysis
3.3 Asia Skeletal Disease Drug Market Development Trend
CHAPTER FOUR 2013-2018 ASIA SKELETAL DISEASE DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
4.1 2013-2018 Skeletal Disease Drug Capacity Production Overview
4.2 2013-2018 Skeletal Disease Drug Production Market Share Analysis
4.3 2013-2018 Skeletal Disease Drug Demand Overview
4.4 2013-2018 Skeletal Disease Drug Supply Demand and Shortage
4.5 2013-2018 Skeletal Disease Drug Import Export Consumption
4.6 2013-2018 Skeletal Disease Drug Cost Price Production Value Gross Margin
CHAPTER FIVE ASIA SKELETAL DISEASE DRUG KEY MANUFACTURERS ANALYSIS
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
CHAPTER SIX ASIA SKELETAL DISEASE DRUG INDUSTRY DEVELOPMENT TREND
6.1 2018-2022 Skeletal Disease Drug Capacity Production Overview
6.2 2018-2022 Skeletal Disease Drug Production Market Share Analysis
6.3 2018-2022 Skeletal Disease Drug Demand Overview
6.4 2018-2022 Skeletal Disease Drug Supply Demand and Shortage
6.5 2018-2022 Skeletal Disease Drug Import Export Consumption
6.6 2018-2022 Skeletal Disease Drug Cost Price Production Value Gross Margin
PART III NORTH AMERICAN SKELETAL DISEASE DRUG INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER SEVEN NORTH AMERICAN SKELETAL DISEASE DRUG MARKET ANALYSIS
7.1 North American Skeletal Disease Drug Product Development History
7.2 North American Skeletal Disease Drug Competitive Landscape Analysis
7.3 North American Skeletal Disease Drug Market Development Trend
CHAPTER EIGHT 2013-2018 NORTH AMERICAN SKELETAL DISEASE DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
8.1 2013-2018 Skeletal Disease Drug Capacity Production Overview
8.2 2013-2018 Skeletal Disease Drug Production Market Share Analysis
8.3 2013-2018 Skeletal Disease Drug Demand Overview
8.4 2013-2018 Skeletal Disease Drug Supply Demand and Shortage
8.5 2013-2018 Skeletal Disease Drug Import Export Consumption
8.6 2013-2018 Skeletal Disease Drug Cost Price Production Value Gross Margin
CHAPTER NINE NORTH AMERICAN SKELETAL DISEASE DRUG KEY MANUFACTURERS ANALYSIS
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
CHAPTER TEN NORTH AMERICAN SKELETAL DISEASE DRUG INDUSTRY DEVELOPMENT TREND
10.1 2018-2022 Skeletal Disease Drug Capacity Production Overview
10.2 2018-2022 Skeletal Disease Drug Production Market Share Analysis
10.3 2018-2022 Skeletal Disease Drug Demand Overview
10.4 2018-2022 Skeletal Disease Drug Supply Demand and Shortage
10.5 2018-2022 Skeletal Disease Drug Import Export Consumption
10.6 2018-2022 Skeletal Disease Drug Cost Price Production Value Gross Margin
PART IV EUROPE SKELETAL DISEASE DRUG INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER ELEVEN EUROPE SKELETAL DISEASE DRUG MARKET ANALYSIS
11.1 Europe Skeletal Disease Drug Product Development History
11.2 Europe Skeletal Disease Drug Competitive Landscape Analysis
11.3 Europe Skeletal Disease Drug Market Development Trend
CHAPTER TWELVE 2013-2018 EUROPE SKELETAL DISEASE DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
12.1 2013-2018 Skeletal Disease Drug Capacity Production Overview
12.2 2013-2018 Skeletal Disease Drug Production Market Share Analysis
12.3 2013-2018 Skeletal Disease Drug Demand Overview
12.4 2013-2018 Skeletal Disease Drug Supply Demand and Shortage
12.5 2013-2018 Skeletal Disease Drug Import Export Consumption
12.6 2013-2018 Skeletal Disease Drug Cost Price Production Value Gross Margin
CHAPTER THIRTEEN EUROPE SKELETAL DISEASE DRUG KEY MANUFACTURERS ANALYSIS
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
CHAPTER FOURTEEN EUROPE SKELETAL DISEASE DRUG INDUSTRY DEVELOPMENT TREND
14.1 2018-2022 Skeletal Disease Drug Capacity Production Overview
14.2 2018-2022 Skeletal Disease Drug Production Market Share Analysis
14.3 2018-2022 Skeletal Disease Drug Demand Overview
14.4 2018-2022 Skeletal Disease Drug Supply Demand and Shortage
14.5 2018-2022 Skeletal Disease Drug Import Export Consumption
14.6 2018-2022 Skeletal Disease Drug Cost Price Production Value Gross Margin
PART V SKELETAL DISEASE DRUG MARKETING CHANNELS AND INVESTMENT FEASIBILITY
CHAPTER FIFTEEN SKELETAL DISEASE DRUG MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS
15.1 Skeletal Disease Drug Marketing Channels Status
15.2 Skeletal Disease Drug Marketing Channels Characteristic
15.3 Skeletal Disease Drug Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals
CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis
CHAPTER SEVENTEEN SKELETAL DISEASE DRUG NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS
17.1 Skeletal Disease Drug Market Analysis
17.2 Skeletal Disease Drug Project SWOT Analysis
17.3 Skeletal Disease Drug New Project Investment Feasibility Analysis
PART VI GLOBAL SKELETAL DISEASE DRUG INDUSTRY CONCLUSIONS
CHAPTER EIGHTEEN 2013-2018 GLOBAL SKELETAL DISEASE DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
18.1 2013-2018 Skeletal Disease Drug Capacity Production Overview
18.2 2013-2018 Skeletal Disease Drug Production Market Share Analysis
18.3 2013-2018 Skeletal Disease Drug Demand Overview
18.4 2013-2018 Skeletal Disease Drug Supply Demand and Shortage
18.5 2013-2018 Skeletal Disease Drug Import Export Consumption
18.6 2013-2018 Skeletal Disease Drug Cost Price Production Value Gross Margin
CHAPTER NINETEEN GLOBAL SKELETAL DISEASE DRUG INDUSTRY DEVELOPMENT TREND
19.1 2018-2022 Skeletal Disease Drug Capacity Production Overview
19.2 2018-2022 Skeletal Disease Drug Production Market Share Analysis
19.3 2018-2022 Skeletal Disease Drug Demand Overview
19.4 2018-2022 Skeletal Disease Drug Supply Demand and Shortage
19.5 2018-2022 Skeletal Disease Drug Import Export Consumption
19.6 2018-2022 Skeletal Disease Drug Cost Price Production Value Gross Margin
CHAPTER TWENTY GLOBAL SKELETAL DISEASE DRUG INDUSTRY RESEARCH CONCLUSIONS
CHAPTER ONE SKELETAL DISEASE DRUG INDUSTRY OVERVIEW
1.1 Skeletal Disease Drug Definition
1.2 Skeletal Disease Drug Classification Analysis
1.2.1 Skeletal Disease Drug Main Classification Analysis
1.2.2 Skeletal Disease Drug Main Classification Share Analysis
1.3 Skeletal Disease Drug Application Analysis
1.3.1 Skeletal Disease Drug Main Application Analysis
1.3.2 Skeletal Disease Drug Main Application Share Analysis
1.4 Skeletal Disease Drug Industry Chain Structure Analysis
1.5 Skeletal Disease Drug Industry Development Overview
1.5.1 Skeletal Disease Drug Product History Development Overview
1.5.1 Skeletal Disease Drug Product Market Development Overview
1.6 Skeletal Disease Drug Global Market Comparison Analysis
1.6.1 Skeletal Disease Drug Global Import Market Analysis
1.6.2 Skeletal Disease Drug Global Export Market Analysis
1.6.3 Skeletal Disease Drug Global Main Region Market Analysis
1.6.4 Skeletal Disease Drug Global Market Comparison Analysis
1.6.5 Skeletal Disease Drug Global Market Development Trend Analysis
CHAPTER TWO SKELETAL DISEASE DRUG UP AND DOWN STREAM INDUSTRY ANALYSIS
2.1 Upstream Raw Materials Analysis
2.1.1 Upstream Raw Materials Price Analysis
2.1.2 Upstream Raw Materials Market Analysis
2.1.3 Upstream Raw Materials Market Trend
2.2 Down Stream Market Analysis
2.1.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis
PART II ASIA SKELETAL DISEASE DRUG INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER THREE ASIA SKELETAL DISEASE DRUG MARKET ANALYSIS
3.1 Asia Skeletal Disease Drug Product Development History
3.2 Asia Skeletal Disease Drug Competitive Landscape Analysis
3.3 Asia Skeletal Disease Drug Market Development Trend
CHAPTER FOUR 2013-2018 ASIA SKELETAL DISEASE DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
4.1 2013-2018 Skeletal Disease Drug Capacity Production Overview
4.2 2013-2018 Skeletal Disease Drug Production Market Share Analysis
4.3 2013-2018 Skeletal Disease Drug Demand Overview
4.4 2013-2018 Skeletal Disease Drug Supply Demand and Shortage
4.5 2013-2018 Skeletal Disease Drug Import Export Consumption
4.6 2013-2018 Skeletal Disease Drug Cost Price Production Value Gross Margin
CHAPTER FIVE ASIA SKELETAL DISEASE DRUG KEY MANUFACTURERS ANALYSIS
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
CHAPTER SIX ASIA SKELETAL DISEASE DRUG INDUSTRY DEVELOPMENT TREND
6.1 2018-2022 Skeletal Disease Drug Capacity Production Overview
6.2 2018-2022 Skeletal Disease Drug Production Market Share Analysis
6.3 2018-2022 Skeletal Disease Drug Demand Overview
6.4 2018-2022 Skeletal Disease Drug Supply Demand and Shortage
6.5 2018-2022 Skeletal Disease Drug Import Export Consumption
6.6 2018-2022 Skeletal Disease Drug Cost Price Production Value Gross Margin
PART III NORTH AMERICAN SKELETAL DISEASE DRUG INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER SEVEN NORTH AMERICAN SKELETAL DISEASE DRUG MARKET ANALYSIS
7.1 North American Skeletal Disease Drug Product Development History
7.2 North American Skeletal Disease Drug Competitive Landscape Analysis
7.3 North American Skeletal Disease Drug Market Development Trend
CHAPTER EIGHT 2013-2018 NORTH AMERICAN SKELETAL DISEASE DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
8.1 2013-2018 Skeletal Disease Drug Capacity Production Overview
8.2 2013-2018 Skeletal Disease Drug Production Market Share Analysis
8.3 2013-2018 Skeletal Disease Drug Demand Overview
8.4 2013-2018 Skeletal Disease Drug Supply Demand and Shortage
8.5 2013-2018 Skeletal Disease Drug Import Export Consumption
8.6 2013-2018 Skeletal Disease Drug Cost Price Production Value Gross Margin
CHAPTER NINE NORTH AMERICAN SKELETAL DISEASE DRUG KEY MANUFACTURERS ANALYSIS
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
CHAPTER TEN NORTH AMERICAN SKELETAL DISEASE DRUG INDUSTRY DEVELOPMENT TREND
10.1 2018-2022 Skeletal Disease Drug Capacity Production Overview
10.2 2018-2022 Skeletal Disease Drug Production Market Share Analysis
10.3 2018-2022 Skeletal Disease Drug Demand Overview
10.4 2018-2022 Skeletal Disease Drug Supply Demand and Shortage
10.5 2018-2022 Skeletal Disease Drug Import Export Consumption
10.6 2018-2022 Skeletal Disease Drug Cost Price Production Value Gross Margin
PART IV EUROPE SKELETAL DISEASE DRUG INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER ELEVEN EUROPE SKELETAL DISEASE DRUG MARKET ANALYSIS
11.1 Europe Skeletal Disease Drug Product Development History
11.2 Europe Skeletal Disease Drug Competitive Landscape Analysis
11.3 Europe Skeletal Disease Drug Market Development Trend
CHAPTER TWELVE 2013-2018 EUROPE SKELETAL DISEASE DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
12.1 2013-2018 Skeletal Disease Drug Capacity Production Overview
12.2 2013-2018 Skeletal Disease Drug Production Market Share Analysis
12.3 2013-2018 Skeletal Disease Drug Demand Overview
12.4 2013-2018 Skeletal Disease Drug Supply Demand and Shortage
12.5 2013-2018 Skeletal Disease Drug Import Export Consumption
12.6 2013-2018 Skeletal Disease Drug Cost Price Production Value Gross Margin
CHAPTER THIRTEEN EUROPE SKELETAL DISEASE DRUG KEY MANUFACTURERS ANALYSIS
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
CHAPTER FOURTEEN EUROPE SKELETAL DISEASE DRUG INDUSTRY DEVELOPMENT TREND
14.1 2018-2022 Skeletal Disease Drug Capacity Production Overview
14.2 2018-2022 Skeletal Disease Drug Production Market Share Analysis
14.3 2018-2022 Skeletal Disease Drug Demand Overview
14.4 2018-2022 Skeletal Disease Drug Supply Demand and Shortage
14.5 2018-2022 Skeletal Disease Drug Import Export Consumption
14.6 2018-2022 Skeletal Disease Drug Cost Price Production Value Gross Margin
PART V SKELETAL DISEASE DRUG MARKETING CHANNELS AND INVESTMENT FEASIBILITY
CHAPTER FIFTEEN SKELETAL DISEASE DRUG MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS
15.1 Skeletal Disease Drug Marketing Channels Status
15.2 Skeletal Disease Drug Marketing Channels Characteristic
15.3 Skeletal Disease Drug Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals
CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis
CHAPTER SEVENTEEN SKELETAL DISEASE DRUG NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS
17.1 Skeletal Disease Drug Market Analysis
17.2 Skeletal Disease Drug Project SWOT Analysis
17.3 Skeletal Disease Drug New Project Investment Feasibility Analysis
PART VI GLOBAL SKELETAL DISEASE DRUG INDUSTRY CONCLUSIONS
CHAPTER EIGHTEEN 2013-2018 GLOBAL SKELETAL DISEASE DRUG PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
18.1 2013-2018 Skeletal Disease Drug Capacity Production Overview
18.2 2013-2018 Skeletal Disease Drug Production Market Share Analysis
18.3 2013-2018 Skeletal Disease Drug Demand Overview
18.4 2013-2018 Skeletal Disease Drug Supply Demand and Shortage
18.5 2013-2018 Skeletal Disease Drug Import Export Consumption
18.6 2013-2018 Skeletal Disease Drug Cost Price Production Value Gross Margin
CHAPTER NINETEEN GLOBAL SKELETAL DISEASE DRUG INDUSTRY DEVELOPMENT TREND
19.1 2018-2022 Skeletal Disease Drug Capacity Production Overview
19.2 2018-2022 Skeletal Disease Drug Production Market Share Analysis
19.3 2018-2022 Skeletal Disease Drug Demand Overview
19.4 2018-2022 Skeletal Disease Drug Supply Demand and Shortage
19.5 2018-2022 Skeletal Disease Drug Import Export Consumption
19.6 2018-2022 Skeletal Disease Drug Cost Price Production Value Gross Margin
CHAPTER TWENTY GLOBAL SKELETAL DISEASE DRUG INDUSTRY RESEARCH CONCLUSIONS
